Ishihara H - Search Results

1

First-line dual immune checkpoint inhibitor therapies versus combination therapies comprising immune checkpoint inhibitors and tyrosine kinase inhibitors for advanced renal cell carcinoma: a comparative analysis of the effectiveness using real-world data.

Ishihara H, Omae K, Nemoto Y, Ishiyama R, Tachibana H, Nishimura K, Ikeda T, Kobari Y, Fukuda H, Yoshida K, Shimmura H, Hashimoto Y, Iizuka J, Kondo T, Takagi T. Ishihara H, et al. Int J Clin Oncol. 2024 Apr;29(4):473-480. doi: 10.1007/s10147-024-02471-w. Epub 2024 Feb 12. Int J Clin Oncol. 2024. PMID: 38345708

2

The magnitude of best tumor shrinkage during second-line targeted therapy affects progression-free survival but not overall survival in patients with metastatic renal cell carcinoma.

Ishihara H, Kondo T, Omae K, Takagi T, Izuka J, Kobayashi H, Tanabe K. Ishihara H, et al. Jpn J Clin Oncol. 2016 Mar 8;46(6):568-574. doi: 10.1093/jjco/hyw024. Jpn J Clin Oncol. 2016. PMID: 26962242

3

Sarcopenia and the Modified Glasgow Prognostic Score are Significant Predictors of Survival Among Patients with Metastatic Renal Cell Carcinoma Who are Receiving First-Line Sunitinib Treatment.

Ishihara H, Kondo T, Omae K, Takagi T, Iizuka J, Kobayashi H, Tanabe K. Ishihara H, et al. Target Oncol. 2016 Oct;11(5):605-617. doi: 10.1007/s11523-016-0430-0. Target Oncol. 2016. PMID: 27023922

4

Late recurrence of a malignant hypoglycemia-inducing pelvic solitary fibrous tumor secreting high-molecular-weight insulin-like growth factor-II: A case report with protein analysis.

Ishihara H, Omae K, Iizuka J, Kobayashi H, Fukuda I, Kondo T, Hizuka N, Nagashima Y, Tanabe K. Ishihara H, et al. Oncol Lett. 2016 Jul;12(1):479-484. doi: 10.3892/ol.2016.4665. Epub 2016 Jun 1. Oncol Lett. 2016. PMID: 27347168 Free PMC article.

5

Sarcopenia predicts survival outcomes among patients with urothelial carcinoma of the upper urinary tract undergoing radical nephroureterectomy: a retrospective multi-institution study.

Ishihara H, Kondo T, Omae K, Takagi T, Iizuka J, Kobayashi H, Hashimoto Y, Tanabe K. Ishihara H, et al. Int J Clin Oncol. 2017 Feb;22(1):136-144. doi: 10.1007/s10147-016-1021-x. Epub 2016 Jul 15. Int J Clin Oncol. 2017. PMID: 27422388

6

Effect of the timing of best tumor shrinkage on survival of patients with metastatic renal cell carcinoma who received first-line tyrosine kinase inhibitor therapy.

Ishihara H, Yagisawa T, Kondo T, Omae K, Takagi T, Iizuka J, Kobayashi H, Tanabe K. Ishihara H, et al. Int J Clin Oncol. 2017 Feb;22(1):126-135. doi: 10.1007/s10147-016-1032-7. Epub 2016 Aug 22. Int J Clin Oncol. 2017. PMID: 27549785

7

Evaluation of tumor burden after sequential molecular-targeted therapy in patients with metastatic renal cell carcinoma.

Ishihara H, Kondo T, Yoshida K, Omae K, Takagi T, Iizuka J, Kobayashi H, Tanabe K. Ishihara H, et al. Jpn J Clin Oncol. 2017 Mar 1;47(3):226-232. doi: 10.1093/jjco/hyw196. Jpn J Clin Oncol. 2017. PMID: 28031355

8

Effect of Systemic Inflammation on Survival in Patients With Metastatic Renal Cell Carcinoma Receiving Second-line Molecular-targeted Therapy.

Ishihara H, Kondo T, Yoshida K, Omae K, Takagi T, Iizuka J, Tanabe K. Ishihara H, et al. Clin Genitourin Cancer. 2017 Aug;15(4):495-501. doi: 10.1016/j.clgc.2017.01.018. Epub 2017 Feb 1. Clin Genitourin Cancer. 2017. PMID: 28363437

9

Evaluation of Preoperative Aspartate Transaminase/Alanine Transaminase Ratio as an Independent Predictive Biomarker in Patients With Metastatic Renal Cell Carcinoma Undergoing Cytoreductive Nephrectomy: A Propensity Score Matching Study.

Ishihara H, Kondo T, Yoshida K, Omae K, Takagi T, Iizuka J, Tanabe K. Ishihara H, et al. Clin Genitourin Cancer. 2017 Oct;15(5):598-604. doi: 10.1016/j.clgc.2017.04.011. Epub 2017 Apr 20. Clin Genitourin Cancer. 2017. PMID: 28495053

10

Preoperative controlling nutritional status (CONUT) score as a novel predictive biomarker of survival in patients with localized urothelial carcinoma of the upper urinary tract treated with radical nephroureterectomy.

Ishihara H, Kondo T, Yoshida K, Omae K, Takagi T, Iizuka J, Tanabe K. Ishihara H, et al. Urol Oncol. 2017 Sep;35(9):539.e9-539.e16. doi: 10.1016/j.urolonc.2017.04.012. Epub 2017 May 9. Urol Oncol. 2017. PMID: 28499734

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,501 results

Search Page